Physician-researchers from Baylor Scott & White Health played a prominent role at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting 2023, held Nov. 10-14 in Boston. They presented the latest insights from one of the largest multispecialty transplant centers in the nation: Baylor Scott & White Annette C. and Harold C. Simmons Transplant Institute in Dallas.
Patients who are admitted to the hospital with cirrhosis have significant morbidity and mortality when they present with complications of end-stage liver disease. Complications such as hepatic encephalopathy and gastrointestinal bleeding lead to increased length of stay, readmission, intensive care utilization and inpatient mortality.
Sumeet Asrani, MD, MSc, has been promoted to chief of hepatology and liver transplantation, Baylor Scott & White Annette C. and Harold C. Simmons Transplant Institute. Dr. Asrani has served as the medical director of the Center for Advanced Liver Disease since 2016. In addition, he has provided clinical care at both Baylor University Medical Center (Baylor Dallas), part of Baylor Scott & White Health, and Baylor Scott & White Medical Center – Waxahachie.
Patients who live in the Austin area can now undergo liver transplant evaluations (LTE) at the Baylor Scott & White Transplant Hepatology Clinic in Round Rock, Texas. The first LTEs outside of Baylor University Medical Center (Baylor Dallas), part of Baylor Scott & White Health, and Baylor Scott & White All Saints Medical Center – Fort Worth, began the last week of January.
In Texas, a disproportionate number of people have non-alcoholic fatty liver disease, non-alcoholic steatohepatitis (NASH) and NASH cirrhosis. Combine these conditions with alcohol misuse, and you have a state with the highest rate of liver cancer in the nation.
